Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
05/2012
05/09/2012CN101818133B VSIG4 (V-set and Ig domain containing 4) and IGRP (glucose-6-phosphatase catalytic subunit-related protein) dual-gene coexpression recombinant adenovirus as well as preparation method and application thereof
05/09/2012CN101724607B Bacteriophage EK99-C of enterotoxigenic Escherichia coil ETEC-K99 and application thereof
05/09/2012CN101649294B Strain containing hypotoxicity virus CHV1-CN280 for preventing and treating chestnut blight
05/09/2012CN101633909B Attenuated live vaccine strain for preventing pig-pig infection breeding and respiratory syndrome
05/08/2012US8173136 Attenuated recombinant newcastle disease virus and vaccine containing the same
05/08/2012CA2533338C Viral vectors
05/03/2012WO2012058673A2 Enhanced cancer treatment and monitoring using recombinant vectors
05/03/2012WO2012057643A1 A method of producing bacteriophage preparations comprising purification using affinity chromatography
05/03/2012WO2012057363A1 Adeno-associated virus virions for transferring genes into neural cells
05/03/2012WO2012056327A2 A method for increasing the replication of oncolytic hsvs in highly resistant tumor cells using mtor pathway and pi3k inhibitors
05/03/2012WO2011138053A8 Modified rodent parvovirus capable of propagating and spreading through human gliomas
05/03/2012US20120108466 Immunoglobulin libraries
05/03/2012US20120107912 Cell lysis device and methods of lysing cells or viruses
05/03/2012US20120107911 Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
05/03/2012US20120107910 Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same
05/03/2012US20120107909 Novel hiv-2 isolate
05/03/2012US20120107358 Subgenomic replicons of the flavivirus dengue
05/03/2012US20120107357 Novel divergent picornavirus: cosavirus
05/03/2012US20120107356 Composition useful as rotavirus vaccine and a method therefor
05/03/2012US20120107355 Method of rapidly producing improved vaccines for animals
05/03/2012US20120107350 Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof
05/03/2012US20120107320 Antibodies specifically directed to the soluble form of ctla-4
05/03/2012CA2816570A1 Enhanced cancer treatment and monitoring using recombinant vectors
05/02/2012EP2445928A1 Chimeric influenza virus-like particles comprising hemagglutinin
05/02/2012EP2445927A1 Lipidated tumor- associated antigens and immunotherapeutic compositions
05/02/2012EP1993603B1 Hepatitis c virus non structural fusion protein
05/02/2012CN102438658A Non-integrating retroviral vector vaccines
05/02/2012CN102433309A Complete gene sequence determination for G5-type human rotavirus after MA104 culture
05/02/2012CN102430125A Heat-resistant stabilizer for chicken embryos fluid lyophilization, as well as preparation method and application thereof
05/02/2012CN101760475B Recombinant retroviral vector
05/01/2012US8168426 Multiple inducible gene regulation system
05/01/2012US8168418 Expression of HIV polypeptides and production of virus-like particles
05/01/2012US8168200 Vaccine against african horse sickness virus
05/01/2012US8168190 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
05/01/2012US8168168 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
05/01/2012CA2456083C Acylthiols and component thiol compositions as anti-hiv and anti-retroviral agents
04/2012
04/26/2012WO2012052158A2 Retargeting of rat parvovirus h-1pv to cancer cells through genetic engineering of its capsid
04/26/2012WO2011044561A9 Attenuated influenza viruses and vaccines
04/26/2012WO2000053787A9 Prrsv vaccines
04/26/2012US20120100576 Perfusion bioreactor
04/26/2012US20120100574 Flavivirus-based system for production of hepatitis c virus (hcv)
04/26/2012US20120100522 Stabilized chemical dehydration of biological material
04/26/2012US20120100181 Attenuation of Encephalitogenic Alphavirus and Uses Thereof
04/26/2012US20120100178 Compositions And Methods For Treatment Of Microbial Infections
04/26/2012US20120100168 Cyclovirus and methods of use
04/26/2012US20120100109 Method for increasing the replication of oncolytic HSVs in highly resistant tumor cells using mTOR pathway and PI3K inhibitors
04/26/2012US20120100104 Antiviral Compounds And Uses Thereof
04/26/2012CA2814235A1 Retargeting of rat parvovirus h-1pv to cancer cells through genetic engineering of its capsid
04/25/2012EP2443241A1 Production of viral capsids
04/25/2012EP2443233A1 Improved methods for purification of recombinant aav vectors
04/25/2012EP2443232A2 System for the heterologous expression of a viral protein in a ciliate host cell
04/25/2012EP2078083B1 A novel canine influenza virus and vaccine therefore
04/25/2012EP1636371B1 Negative strand rna virus replicon
04/25/2012CN1768078B Antibodies directed against hepatitis c virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
04/25/2012CN101818132B Construction of chimeric rabies strain rLEP333Q-L(H) and research on biological function thereof
04/25/2012CN101671656B 溶瘤Ⅰ型单纯疱疹病毒靶向和杀伤前列腺肿瘤细胞的方法 Oncolytic herpes simplex virus type Ⅰ targeting and killing of tumor cells of the prostate
04/25/2012CN101392027B 一种治疗阿尔茨海默病的融合蛋白及其制备方法 A fusion protein of Alzheimer's disease and its preparation method of treatment
04/25/2012CN101353663B 一种抗i型糖尿病融合蛋白及其制备方法 An anti-i fusion protein of Diabetes and its preparation method
04/25/2012CN101069744B 流感疫苗组合物 Influenza vaccine composition
04/24/2012US8163712 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
04/24/2012US8163548 Recombinant bicistronic flaviviruses and methods of use thereof
04/24/2012US8163547 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
04/24/2012US8163543 AAV vectors produced in insect cells
04/24/2012US8163531 Purification of vaccinia viruses using hydrophobic interaction chromatography
04/24/2012US8163530 Nucleic acids encoding respiratory syncytial virus subgroup B strain 9320
04/24/2012US8163293 Modified Vaccinia Virus Ankara for the vaccination of neonates
04/24/2012US8163292 Herpes simplex viruses and methods of viral replication
04/24/2012CA2532460C Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
04/19/2012WO2012051491A1 Compositions and methods for controlling neurotropic viral pathogenesis by micro-rna targeting
04/19/2012WO2012050229A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses
04/19/2012WO2012050193A1 Ebola virus liposome vaccine
04/19/2012WO2012049172A1 Phage receptor proteins in fermentation processes
04/19/2012WO2012048430A1 Affinity-conjugated nucleoprotein-papaya mosaic virus-like particles and uses thereof
04/19/2012WO2011155727A3 Method for preventing and treating infection caused by salmonella choleraesuis or salmonella dublin
04/19/2012WO2011133902A3 Cell culture medium comprising small peptides
04/19/2012WO2011126856A3 Herpes simplex virus mutant icp0
04/19/2012WO2011116094A3 Live attenuated chimeric porcine circovirus vaccine
04/19/2012US20120095083 Use of triplex structure dna in transferring nucleotide sequences
04/19/2012US20120094271 Selecting for cooperatively interacting molecules
04/19/2012US20120093853 Simian Adenovirus Vectors and Methods of Use
04/19/2012US20120093778 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
04/19/2012US20120093777 Compositions comprising viruses and methods for concentrating virus preparations
04/19/2012US20120093775 Methods and compositions for the treatment of cirrhosis and liver fibrosis
04/19/2012CA2814643A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses
04/18/2012CN102417912A 猪细小病毒样颗粒b细胞表位插入位点的分子设计 Porcine parvovirus-like particles b-cell epitope insertion site of Molecular Design
04/18/2012CN102417896A 一种金黄色葡萄球菌的噬菌体及其应用 One Staphylococcus aureus phage and its application
04/18/2012CN102416174A 猪o型口蹄疫重组噬菌体疫苗及其构建方法 Swine o-mouth disease vaccine and recombinant phage construction method
04/18/2012CN102416173A 预防与猪环状病毒-2相关的心肌炎、流产和宫内感染 Prevention and porcine circovirus -2 associated myocarditis, abortion and intrauterine infection
04/18/2012CN101914503B Canine distemper attenuated vaccine strain and application thereof
04/18/2012CN101875920B DcR3和GAD65双基因共表达重组腺病毒及其制备方法和应用 DcR3 and GAD65 gene co-expression of recombinant adenovirus double its preparation method and application
04/18/2012CN101487016B 禽流感疫苗及其制备方法 Bird flu vaccine and its preparation method
04/18/2012CN101321455B 抗病毒病的嫁接植株和生产相同植株的方法 Grafted plants and plants producing the same way anti-virus disease
04/17/2012US8158602 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
04/17/2012US8158599 Chimeric adenoviruses for use in cancer treatment
04/17/2012US8158418 Chimeric alphavirus replicon particles
04/17/2012US8158416 CDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, and process for the production of such viruses encoding additional antigenically active proteins
04/17/2012US8158130 Method for the preparation of virus-like particles (VLPS) comprising heterologous multiple membrane spanning proteins
04/17/2012CA2481521C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
04/17/2012CA2202090C Papilloma virus-like particles, fusion proteins as well as processes for their production
04/12/2012WO2012046836A1 Hepatitis c virus gene
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 267